Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Juanjie Tang, Youri Lee, Supriya Ravichandran, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103006-103006
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Juanjie Tang, Tanya Novak, Julian Hecker, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination
Lorenza Bellusci, Gabrielle Grubbs, Fatema Tuz Zahra, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Open Access | Times Cited: 8
SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19
Supriya Ravichandran, Juanjie Tang, Gabrielle Grubbs, et al.
Nature Immunology (2021) Vol. 22, Iss. 11, pp. 1452-1464
Open Access | Times Cited: 51
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 31
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
Daniele Focosi, Marco Tuccori, Andreina Baj, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1211-1211
Open Access | Times Cited: 38
Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity
Yu Nakagama, Katherine Candray, Natsuko Kaku, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 6, pp. 780-787
Open Access | Times Cited: 23
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex
Juanjie Tang, Gabrielle Grubbs, Youri Lee, et al.
EBioMedicine (2021) Vol. 74, pp. 103748-103748
Open Access | Times Cited: 20
Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures
Supriya Ravichandran, Gabrielle Grubbs, Juanjie Tang, et al.
Science Advances (2021) Vol. 7, Iss. 42
Open Access | Times Cited: 18
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19
Fatema Tuz Zahra, Lorenza Bellusci, Gabrielle Grubbs, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1044-1045
Open Access | Times Cited: 12
Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia
Lorenza Bellusci, Gabrielle Grubbs, Pragya Srivastava, et al.
Blood (2022) Vol. 139, Iss. 18, pp. 2842-2846
Open Access | Times Cited: 11
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019
Juanjie Tang, Gabrielle Grubbs, Youri Lee, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 4, pp. 655-663
Open Access | Times Cited: 9
Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C
Juanjie Tang, Adrienne G. Randolph, Tanya Novak, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 9
Up, up, down, down: the structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system
Sabrina Stäb, Nicholas M. Pearce, Dale E. Tronrud, et al.
Crystallography Reviews (2024), pp. 1-44
Open Access | Times Cited: 1
A role for Nucleocapsid-specific antibody function in Covid-19 Convalescent plasma therapy
Jonathan D. Herman, Chuangqi Wang, John S. Burke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Intravenous Human Immunoglobulins Neutralizes Omicron Subvariants BA.1, BA.2, BA.2.12.1, BA.3, and BA.4/BA.5 for Treatment of Coronavirus Disease 2019
Mayanka Awasthi, Hana Golding, Surender Khurana
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e503-e506
Open Access | Times Cited: 8
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Lorenza Bellusci, Gabrielle Grubbs, Shaimaa Sait, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Adult Syrian Hamsters
Charles B. Stauft, Million A. Tegenge, Surender Khurana, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e459-e465
Open Access | Times Cited: 9
Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
Yinon Levy, Ron Alcalay, Anat Zvi, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 251-251
Open Access | Times Cited: 6
Profiling of linear B-cell epitopes against human coronaviruses in pooled sera sampled early in the COVID-19 pandemic
Emil Bach, Mustafa Ghanizada, Nikolaj Kirkby, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C
Lorenza Bellusci, Gabrielle Grubbs, Shaimaa Sait, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 638-638
Open Access
Profiling of linear B-cell epitopes against human coronaviruses in pooled sera sampled early in the COVID-19 pandemic
Emil Bach, Mustafa Ghanizada, Nikolaj Kirkby, et al.
Open Research Europe (2024) Vol. 4, pp. 215-215
Open Access
SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women
Youri Lee, Gabrielle Grubbs, Sabrina Ramelli, et al.
EBioMedicine (2022) Vol. 77, pp. 103940-103940
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top